Ardsley Advisory Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7,500	Closed	-$676K	–	154
2019 Q3	$676K	Buy	+7,500	New	+$676K	0.15%	62
2017 Q4	–	Sell	-97,500	Closed	-$5.98M	–	151
2017 Q3	$5.98M	Buy	97,500 +92,500	+1,850%	+$5.67M	0.79%	38
2017 Q2	$230K	Buy	+5,000	New	+$230K	0.04%	103